Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pozza

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
European Journal of Pharmacology|June 21, 1990
Electrophysiological characterization of a novel potent and orally active NMDA receptor antagonist: CGP 37849 and its ethylester CGP 39551M F Pozza, H R Olpe, F Brugger, et al.
European Journal of Pharmacology|January 20, 2004
Selected amino acids, dipeptides and arylalkylamine derivatives do not act as allosteric modulators at GABAB receptorsStephan Urwyler, Tina Gjoni, Klemens Kaupmann, et al.
Rays|January 1, 1986
Dosimetry in interstitial curietherapy: comments on the Manchester and Paris systems as an introduction to a new system of dosimetryR C Avanzo, G Chierego, C Marchetti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1988
Dosimetric considerations on multiple arc stereotaxic radiotherapyG Chierego, C Marchetti, R C Avanzo, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1989
Excitatory amino acid receptors in rat locus coeruleus. An extracellular in vitro studyH R Olpe, M W Steinmann, F Brugger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1994
Contribution of presynaptic GABA-B receptors to paired-pulse depression of GABA-responses in the hippocampusH R Olpe, M W Steinmann, K Greiner, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancerG Gasparini, F Pozza, R Dittadi, et al.
American Journal of Clinical Oncology|February 1, 1991
Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer. A randomized clinical trialG Gasparini, S Dal Fior, G A Panizzoni, et al.
La Radiologia Medica|March 1, 1989
[Advanced stages of rectosigmoid cancer. The role of postoperative radiotherapy]G Bolzicco, S Favretto, S Dal Fior, et al.
Breast Cancer Research and Treatment|January 1, 1994
A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinomaG Gasparini, P Boracchi, P Bevilacqua, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
European Journal of Pharmacology|June 21, 1990
Electrophysiological characterization of a novel potent and orally active NMDA receptor antagonist: CGP 37849 and its ethylester CGP 39551M F Pozza, H R Olpe, F Brugger, et al.
European Journal of Pharmacology|January 20, 2004
Selected amino acids, dipeptides and arylalkylamine derivatives do not act as allosteric modulators at GABAB receptorsStephan Urwyler, Tina Gjoni, Klemens Kaupmann, et al.
Rays|January 1, 1986
Dosimetry in interstitial curietherapy: comments on the Manchester and Paris systems as an introduction to a new system of dosimetryR C Avanzo, G Chierego, C Marchetti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1988
Dosimetric considerations on multiple arc stereotaxic radiotherapyG Chierego, C Marchetti, R C Avanzo, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1989
Excitatory amino acid receptors in rat locus coeruleus. An extracellular in vitro studyH R Olpe, M W Steinmann, F Brugger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1994
Contribution of presynaptic GABA-B receptors to paired-pulse depression of GABA-responses in the hippocampusH R Olpe, M W Steinmann, K Greiner, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancerG Gasparini, F Pozza, R Dittadi, et al.
American Journal of Clinical Oncology|February 1, 1991
Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer. A randomized clinical trialG Gasparini, S Dal Fior, G A Panizzoni, et al.
La Radiologia Medica|March 1, 1989
[Advanced stages of rectosigmoid cancer. The role of postoperative radiotherapy]G Bolzicco, S Favretto, S Dal Fior, et al.
Breast Cancer Research and Treatment|January 1, 1994
A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinomaG Gasparini, P Boracchi, P Bevilacqua, et al.
Pageof 9